Immunomedics, Inc.
Immunomedics, Inc. (United States) holds 0 active US FDA Type II Drug Master Files and 3 inactive. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Immunomedics, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/immunomedics-inc
Overview
Immunomedics, Inc. is a biopharmaceutical company known for developing antibody-drug conjugates for the treatment of cancer. It is a subsidiary of Gilead Sciences, Inc., which acquired the company to strengthen its oncology portfolio.
Therapeutic areas
API / Drug Master Files
Immunomedics, Inc. holds 0 active (3 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- MURINE MONOCLONAL ANTIBODY AND F(AB)2 FRAGMENT (IMMU-14) TO CARCINOEMBRYONIC ANTIGEN (CEA)Inactive1990-09-14
- MURINE MONOCLONAL ANTIBODY (IMM-LL-2) TO B-CELL LYMPHOMA AND LEUKEMIA CELLSInactive1989-11-02
- MURINE MONOCLONAL ANTIBODY (IMMU-31) TO ALPHA-FETOPROTEINInactive1989-04-28
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Immunomedics, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Immunomedics, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.